OmniAb, Inc. Common Stock

OABINASDAQUSD
1.55 USD
0.01 (0.33%)🟢LIVE (AS OF 02:53 PM EDT)
🟢Market: OPEN
Open?$1.52
High?$1.57
Low?$1.53
Prev. Close?$1.54
Volume?172.2K
Avg. Volume?305.1K
VWAP?$1.54
Rel. Volume?0.56x
Bid / Ask
Bid?$1.53 × 1.1K
Ask?$1.54 × 100
Spread?$0.01
Midpoint?$1.54
Valuation & Ratios
Market Cap?223.0M
Shares Out?144.8M
Float?73.9M
Float %?51.3%
P/E Ratio?N/A
P/B Ratio?0.83
EPS?-$0.45
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?4.02Strong
Quick Ratio?4.02Strong
Cash Ratio?1.57Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUED
Score
67/100
P/E?
N/A
P/B?
0.83CHEAP
P/S?
11.94HIGH
P/FCF?
N/A
EV/EBITDA?
-4.2CHEAP
EV/Sales?
10.58HIGH
Returns & Efficiency
ROE?
-24.3%WEAK
ROA?
-21.5%WEAK
Cash Flow & Enterprise
FCF?$-37020000
Enterprise Value?$197.4M
Related Companies
Loading...
News
Profile
OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. At the heart of the OmniAb platform is what it calls Biological Intelligence, which powers the immune systems of proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.
Employees
89
Market Cap
223.0M
Industry
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Listed
2022-11-01
Address
5980 HORTON STREET
EMERYVILLE, CA 94608
Phone: 510-250-7800